News about Logistics & Distribution

Central Bureau of Narcotics and Pharmexcil Sign MoU to Regulate Controlled Substances in Pharma Exports

Central Bureau of Narcotics and Pharmexcil Sign MoU to Regulate Controlled Substances in Pharma Exports

Central Bureau of Narcotics (CBN) and Pharmexcil sign an MoU to strengthen regulation of controlled substances in pharma exports through a voluntary industry code of conduct.

Logistics & Distribution | 26/08/2026 | By News Bureau

CCT Cuts Pharma Cold Chain Reships by 84 Percent with Smaller Reusable Shipper

CCT Cuts Pharma Cold Chain Reships by 84 Percent with Smaller Reusable Shipper

The pharmaceutical cold chain logistics market is projected to grow from USD 22.75 billion in 2025 to USD 44.1 billion by 2033, at a 9.12 percent Compound Annual Growth Rate (CAGR).

Logistics & Distribution | 19/08/2026 | By News Bureau

Ember LifeSciences and Alfresa Partner to Strengthen Japan's Pharma Cold Chain

Ember LifeSciences and Alfresa Partner to Strengthen Japan's Pharma Cold Chain

Ember LifeSciences and Alfresa have formed a capital and business alliance to enhance Japan's pharmaceutical cold chain with advanced transport and traceability.

Logistics & Distribution | 30/07/2026 | By News Bureau 102

Novo Nordisk's Wegovy Gets EU Approval for 48-Hour Controlled-Temperature Delivery

Novo Nordisk's Wegovy Gets EU Approval for 48-Hour Controlled-Temperature Delivery

Novo Nordisk’s Wegovy becomes the first GLP-1 weight-loss treatment approved in the EU for 48-hour controlled-temperature delivery, improving storage flexibility and patient access.

Logistics & Distribution | 11/04/2026 | By News Bureau 243

Centre Engages Domestic Firms to Stabilise Methanol Supply for Drug Industry

Centre Engages Domestic Firms to Stabilise Methanol Supply for Drug Industry

The Indian government is actively engaging domestic producers, including Assam Petro-Chemicals Limited and Gujarat Narmada Valley Fertilizers & Chemicals Limited, to secure a steady supply of methanol for the pharmaceutical sector amid ongoing disruptions in West Asia.

Logistics & Distribution | 10/04/2026 | By Darshana 219

UPSIDA, JNPA Partner to Position Lalitpur Pharma Park as Export Hub

UPSIDA, JNPA Partner to Position Lalitpur Pharma Park as Export Hub

Uttar Pradesh State Industrial Development Authority (UPSIDA) has signed an agreement with Jawaharlal Nehru Port Authority (JNPA) to develop the Lalitpur Pharma Park into a global pharmaceutical export hub.

Logistics & Distribution | 07/04/2026 | By Darshana 195

Pharma Logistics Demand Surges as War Disrupts Global Supply Chains

Pharma Logistics Demand Surges as War Disrupts Global Supply Chains

Pharmaceutical logistics is witnessing a sharp surge in demand as global supply chains face mounting disruptions from geopolitical conflicts, pandemics, and trade uncertainties.

Logistics & Distribution | 06/04/2026 | By Darshana 195

AiMeD Applauds Govt's Duty Waiver on Petrochemicals, Urges GST Cut to Ease Cost Pressures

AiMeD Applauds Govt's Duty Waiver on Petrochemicals, Urges GST Cut to Ease Cost Pressures

The Association of Indian Medical Devices Industry (AiMeD) extends its sincere gratitude to the Government of India, particularly the Ministry of Finance and the Ministry of Commerce & Industry, for the prompt announcement of full customs duty temporary exemption on critical petrochemical products until June 30, 2026.

Logistics & Distribution | 02/04/2026 | By Darshana 288

Glenmark Takes Full Control of Ryaltris in US, Bets on Direct Market Strategy

Glenmark Takes Full Control of Ryaltris in US, Bets on Direct Market Strategy

Glenmark Pharmaceuticals has announced a strategic shift to directly commercialise and distribute its nasal spray Ryaltris in the United States, moving away from its earlier partner-led model.

Logistics & Distribution | 02/04/2026 | By Darshana 794

India Cracks Down on Misuse of GLP-1 Weight Loss Drugs Amid Semaglutide Surge

India Cracks Down on Misuse of GLP-1 Weight Loss Drugs Amid Semaglutide Surge

Central Drugs Standard Control Organisation has initiated a nationwide crackdown to curb potential malpractices in the pharmaceutical supply chain and prevent the unauthorized sale and misuse of GLP-1 receptor agonist-based weight loss drugs, following the rapid entry of multiple generic versions of semaglutide in India.

Logistics & Distribution | 24/03/2026 | By Darshana 174

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members